A Study Evaluating Desvenlafaxine Sustained Release (DVS SR) in Adult Female Outpatients With Fibromyalgia

NCT00696787 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

125

Enrollment

INDUSTRY

Sponsor class

Conditions

Fibromyalgia

Interventions

DRUG: Desvenlafaxine Sustained Release (DVS SR)
DRUG: Lyrica® (Pregabalin)
DRUG: Placebo

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer